| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 216,025 | 494,639 | 570,975 | 540,902 | | Cost of Revenue | 213,408 | 358,883 | 409,765 | 674,352 | | | Gross Profit | 2,617 | 135,756 | 161,210 | (133,450) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 21,884 | 39,372 | 41,353 | 42,303 | | Non Recurring |
-
| (5,440) | (75,063) | 721,410 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (14,669) | 101,824 | 194,920 | (897,163) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 103,002 | 59,442 |
-
|
-
| | Earnings Before Interest And Taxes | (23,352) | 167,530 | 202,423 | (891,146) | | Interest Expense | (29,663) | 7,468 | 22,195 | 13,234 | | Income Before Tax | 6,311 | 160,062 | 180,228 | (904,380) | | Income Tax Expense | 4,468 | 56,809 | 64,919 | (64,396) | | Minority Interest |
-
|
-
|
-
| (19,320) | | | | Net Income From Continuing Ops | 1,843 | 103,253 | 115,309 | (859,314) | | | Non-recurring Events | | Discontinued Operations | 3,021 | 9,836 | (2,554) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,153) | 113,089 | 112,755 | (859,314) | | Preferred Stock And Other Adjustments | 18,048 | (12,870) | (59,305) | (550) | | | Net Income Applicable To Common Shares | $3,895 | $100,219 | $53,450 | ($859,864) |
|
0.29% Nasdaq 
Income Statement
